Weekly growth hormone shot tested in thousands of kids
NCT ID NCT06037473
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is tracking 2,600 Chinese children with growth disorders who are receiving a long-acting growth hormone injection. The goal is to see how well it works and how safe it is over the long term in real-world settings. Researchers will measure changes in height and look for factors that affect treatment success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PEGylated recombinant human growth hormone injection
What this could lead to
If successful, this could confirm a convenient once-weekly growth hormone option for children with growth disorders, improving height outcomes.
What could go wrong
This is an observational registry study, not a controlled trial, so results may be less definitive. Individual responses vary, and long-term safety data are still being collected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TURNER SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Endocrinology, Genetics, Metabolism
RECRUITINGBeijing, Beijing Municipality, 010, China
Contact Phone: •••-•••-•••• Email: •••••@•••••